CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Revenues [Abstract] | ||||
| Total revenue | $ 376,400 | $ 299,398 | $ 1,014,567 | $ 781,070 |
| OPERATING COSTS AND EXPENSES: | ||||
| Cost of revenue | 84,315 | 79,186 | 254,250 | 235,827 |
| Cost of goods sold—pharmacy revenue | 106,172 | 62,302 | 284,360 | 154,753 |
| Marketing and advertising | 109,276 | 90,205 | 288,676 | 237,724 |
| Selling, general, and administrative | 34,971 | 27,544 | 97,049 | 86,662 |
| Technical development | 8,604 | 6,434 | 24,291 | 18,860 |
| Total operating costs and expenses | 343,338 | 265,671 | 948,626 | 733,826 |
| INCOME FROM OPERATIONS | 33,062 | 33,727 | 65,941 | 47,244 |
| INTEREST EXPENSE, NET | (24,330) | (21,105) | (70,141) | (58,885) |
| OTHER INCOME (EXPENSE,) NET | (12) | (206) | (51) | (118) |
| INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT) | 8,720 | 12,416 | (4,251) | (11,759) |
| INCOME TAX EXPENSE (BENEFIT) | 169 | 3,152 | (1,143) | (1,053) |
| NET INCOME (LOSS) | $ 8,551 | $ 9,264 | $ (3,108) | $ (10,706) |
| NET INCOME (LOSS) PER SHARE: | ||||
| Basic (in dollars per share) | $ 0.05 | $ 0.06 | $ (0.02) | $ (0.06) |
| Diluted (in dollars per share) | $ 0.05 | $ 0.06 | $ (0.02) | $ (0.06) |
| WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS: | ||||
| Basic (in shares) | 169,070 | 166,543 | 168,291 | 165,951 |
| Diluted (in shares) | 170,956 | 167,905 | 168,291 | 165,951 |
| OTHER COMPREHENSIVE INCOME (LOSS) NET OF TAX: | ||||
| Gain (loss) on cash flow hedge | $ (1,771) | $ (2,661) | $ (7,203) | $ 1,358 |
| OTHER COMPREHENSIVE INCOME (LOSS) | (1,771) | (2,661) | (7,203) | 1,358 |
| COMPREHENSIVE INCOME (LOSS) | 6,780 | 6,603 | (10,311) | (9,348) |
| Commission | ||||
| Revenues [Abstract] | ||||
| Total revenue | 230,763 | 197,258 | 611,744 | 533,627 |
| Pharmacy | ||||
| Revenues [Abstract] | ||||
| Total revenue | 120,282 | 66,948 | 323,865 | 159,641 |
| Other | ||||
| Revenues [Abstract] | ||||
| Total revenue | $ 25,355 | $ 35,192 | $ 78,958 | $ 87,802 |
| X | ||||||||||
- Definition Cost of Sales No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expenses incurred in the period for information technology and data processing products and services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax of other comprehensive income (loss) attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|